Evotec (EVTCY) News Today → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free EVTCY Stock Alerts $5.25 +0.06 (+1.16%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEQEvotec SE Appoints Dr Christian Wojczewski as Chief Executive Officerfinance.yahoo.com - April 24 at 1:44 AMEQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officermarkets.businessinsider.com - April 23 at 3:37 PMEvotec SE: Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinicfinanznachrichten.de - March 6 at 6:02 PMEvotec SE: Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapiesfinanznachrichten.de - January 10 at 10:16 AMEvotec, Owkin Anounce A.I.-Powered Collaboration In Oncology, Immunology, And Inflammationmarkets.businessinsider.com - January 4 at 2:13 AMEvotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 12 at 12:33 PMEQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate updatemarkets.businessinsider.com - November 8 at 1:25 AM65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singaporefinance.yahoo.com - October 5 at 8:19 AMEvotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economyfinance.yahoo.com - September 27 at 9:19 AMEvotec SE (EVO) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - September 21 at 9:22 AMIs There Now An Opportunity In Evotec SE (ETR:EVT)?finance.yahoo.com - May 30 at 9:33 AMEvotec SE (ETR:EVT) Shares Could Be 37% Below Their Intrinsic Value Estimatefinance.yahoo.com - May 14 at 8:50 AMEvotec SE: Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023finanznachrichten.de - May 13 at 7:54 PMEvotec SE ADR (EVO) Earnings Dates & Reportsinvesting.com - May 12 at 1:20 AMEvotec SE ADR (EVO)investing.com - May 10 at 3:36 PMEvotec SE: Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturingfinanznachrichten.de - May 9 at 3:30 PMEvotec SE Provides Update on Cyber Attackfinance.yahoo.com - April 10 at 10:19 AMEvotec SE: Evotec Receives € 150 m Loan from European Investment Bankfinanznachrichten.de - February 10 at 9:11 AMEQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionmarkets.businessinsider.com - January 31 at 3:09 PMWith 47% ownership, Evotec SE (ETR:EVT) has piqued the interest of institutional investorsca.finance.yahoo.com - December 22 at 11:36 PMEvotec SE: Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibbfinanznachrichten.de - December 17 at 4:09 PMEvotec SE: Just - Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Programfinanznachrichten.de - September 21 at 11:17 PMEvotec: US Unit Gets $49.9 Mln Antibodies Contract From U.S. Department Of Defensemarkets.businessinsider.com - September 20 at 4:03 AMEvotec SE: Evotec Initiates Ground-Breaking for New Biologics Facility J.POD Toulouse, Francefinanznachrichten.de - September 17 at 6:55 PMEvotec SE's (EVOTF) CEO Dr. Werner Lanthaler on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 13 at 7:38 AMEvotec Slips To Loss In Q3, Revenues Rise; Lifts FY22 Revenue View, Backs Adj. EBITDA Forecastnasdaq.com - August 11 at 2:20 AMDGAP-News: Evotec SE reports results for the first half-year 2022 and provides corporate updatesmarkets.businessinsider.com - August 11 at 2:20 AMEvotec SE Reports Results for the First Half-year 2022 and Provides Corporate Updatesfinance.yahoo.com - August 11 at 2:20 AMEvotec SE: Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303finanznachrichten.de - August 10 at 3:24 AMEvotec Q1 Adj. EBITDA Down, Revenues Upnasdaq.com - May 11 at 10:04 AMEvotec SE Fiscal Year 2021 Results: ‘Setting the Pace’ on the Data-Driven R&D Autobahn to Curesapnews.com - April 12 at 2:35 AMEvotec AG: Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Curesfinanznachrichten.de - April 12 at 2:35 AMEvotec SE reports FY resultsseekingalpha.com - April 12 at 2:35 AMEvotec FY21 Net Income Surges, Operating Result Down; Sees Higher Group Revenues In FY22nasdaq.com - April 12 at 2:35 AMEvotec Confirms Goals Of Action Plan 2025markets.businessinsider.com - March 2 at 2:11 AMEvotec, UoB To Expand Molecular Patient Database In Kidney Diseases With Nephrotic Syndromemarkets.businessinsider.com - March 1 at 5:33 AMEvotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assetsuk.finance.yahoo.com - February 4 at 9:39 AMEvotec Signs IPSC-based Drug Discovery Partnership With Boehringer Ingelheim In Ophthalmologynasdaq.com - January 25 at 7:57 AMEvotec Enters Research Partnership With Lilly - Quick Factsnasdaq.com - January 18 at 2:37 AMEvotec Gets 7.5 Mln Euros Grant From German Govt. To Develop Anti Covid-19 Drug EVT075 markets.businessinsider.com - January 3 at 2:55 AMEvotec AG: Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Updatefinanznachrichten.de - November 11 at 1:45 AMDGAP-News: Evotec SE reports results for the first nine months 2021 and provides corporate updatemarkets.businessinsider.com - November 11 at 1:45 AMEvotec SE reports results for the first nine months 2021 and provides corporate updateuk.finance.yahoo.com - November 11 at 1:45 AMEvotec SE Announces Placement of Its Public Offering of American Depositary Sharesfinance.yahoo.com - November 3 at 8:54 PMEvotec SE To Announce Results for the First Nine Months 2021 On 11 November 2021finance.yahoo.com - November 3 at 9:47 AMPasithea and Evotec Team Up — Attempt to Make Headway on Brain Disordersbenzinga.com - November 2 at 11:21 PMEvotec SE : Evotec provides preliminary nine month financial resultsmarkets.businessinsider.com - October 29 at 1:23 AMEvotec SE Targets $576 Million U.S. IPOseekingalpha.com - October 28 at 2:58 PMGerman drug developer Evotec seeks over $9 bln valuation in U.S. IPOreuters.com - October 26 at 7:38 PMGerman biotech Evotec seeks over $9 billion valuation in U.S. IPOreuters.com - October 26 at 7:38 PM Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address 😱 This phenomenon is smashing regular market gains (Ad)Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open. Click here to save your seat and join the next LIVE workshop! EVTCY Media Mentions By Week EVTCY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVTCY News Sentiment▼0.000.34▲Average Medical News Sentiment EVTCY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVTCY Articles This Week▼00▲EVTCY Articles Average Week Get Evotec News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INDV News Today JANX News Today SMMT News Today RYTM News Today MRUS News Today CORT News Today EVO News Today MOR News Today ARVN News Today ACAD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EVTCY) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evotec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
